Stock to Short

This forecast is part of the Top 10 Stocks Package, as one of I Know First’s systematic trading tools. The full package includes a daily prediction for a total of 20 stocks with bullish and bearish signals:

• Top 10 stocks pick for the long position
• Top 10 stocks pick for the short position

Package Name: Top 10 Stocks
Recommended Positions: Short
Forecast Length: 7 Days (03/27/2018 – 04/03/2018)
I Know First Average: 5.45%

9 out of 10 top stock picks from the algorithm decreased as predicted for this short-term forecasting period. SAGE saw monumental growth of 12.42% in just 7 Days. EXAS, and IMMU also had excellent performances with returns of 10.42% and 8.24% respectively. <![CDATA[The package had an overall average return of 5.45%, providing investors with a premium of 7.11% over the S&P 500’s return of -1.66% during the same period.

SAGE Therapeutics, Inc., incorporated on April 16, 2010, is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company’s lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a neurosteroid that acts as a synaptic and extrasynaptic modulator of the Gamma-Amino Butyric Acid-A (GABAA) receptor. The Company’s next-generation product candidates, SAGE-217 and SAGE-689, also target the GABAA receptor system. The Company is focused on developing drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors. The Company’s chemistry platform is focused on chemical scaffolds of endogenous or chemically modified synthetic neuroactive steroid compounds that are allosteric modulators of GABAA or N-Methyl-D-aspartic acid or N-Methyl-D-aspartate (NMDA) receptors.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.